Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis.

Published on Apr 14, 2020in medRxiv
· DOI :10.1101/2020.04.09.20059204
Nathan R. Tucker14
Estimated H-index: 14
Mark Chaffin12
Estimated H-index: 12
(Broad Institute)
+ 10 AuthorsRoby P. Bhattacharyya12
Estimated H-index: 12
(Harvard University)
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection of host cells occurs predominantly via binding of the viral surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. Hypertension and pre-existing cardiovascular disease are risk factors for morbidity from COVID-19, and it remains uncertain whether the use of angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) impacts infection and disease. Here, we aim to shed light on this question by assessing ACE2 expression in normal and diseased human myocardial samples profiled by bulk and single nucleus RNA-seq.
  • References (8)
  • Citations (3)
📖 Papers frequently viewed together
4 Authors (Paolo Verdecchia, ..., Fabio Angeli)
10 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Kevin J. ClerkinH-Index: 9
#2Justin FriedH-Index: 8
Last. LeRoy E. RabbaniH-Index: 30
view all 12 authors...
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and >3 000 000 patients worldwide as of April 28, 2020. COVID-19 is caused by severe acute respiratory syndrome coro...
116 CitationsSource
#1Liang Chen (Fudan University)H-Index: 18
#1Liang Chen (Fudan University)H-Index: 53
Last. Chenglong Xiong (Fudan University)H-Index: 6
view all 5 authors...
A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries. This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition. Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients. Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SA...
64 CitationsSource
#1Nathan R. Tucker (Harvard University)H-Index: 14
#2Mark Chaffin (Broad Institute)H-Index: 12
Last. Irinna Papangeli (Broad Institute)H-Index: 2
view all 18 authors...
Background: The human heart requires a complex ensemble of specialized cell types to perform its essential function. A greater knowledge of the intricate cellular milieu of the heart is critical to...
3 CitationsSource
#1Markus H. Hoffmann (DPZ: German Primate Center)H-Index: 20
#1M. Hoffmann (DPZ: German Primate Center)H-Index: 1
Last. Andreas Nitsche (RKI: Robert Koch Institute)H-Index: 38
view all 13 authors...
Summary The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SA...
1,081 CitationsSource
#1Shaobo ShiH-Index: 7
#2Mu QinH-Index: 3
Last. Qin‐yan ZhaoH-Index: 1
view all 13 authors...
Importance Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited. Objective To explore the association between cardiac injury and mortality in patients with COVID-19. Design, Setting, and Participants This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; ...
241 CitationsSource
#1Michael Letko (NIH: National Institutes of Health)H-Index: 2
#2Andrea Marzi (NIH: National Institutes of Health)H-Index: 34
Last. Vincent J. Munster (NIH: National Institutes of Health)H-Index: 48
view all 3 authors...
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the ...
232 CitationsSource
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor binding and entry by its spike (S) glycoprotein, and infection is sensitive to lysosomotropic agents that perturb endosomal pH. We demonstrate here that the lysosomotropic-agent-mediated block to SARS-CoV infection is overcome by protease treatment of target-cell-associated virus. In addition, SARS-CoV infection was blocked by s...
344 CitationsSource
#2Larissa M. MatukasH-Index: 7
Last. Allan S. DetskyH-Index: 62
view all 21 authors...
ContextSevere acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide.ObjectivesTo describe the clinical characteristics and short-term outcomes of SARS in the first large group of patients in North America; to describe how these patients were treated and the variables associated with poor outcome.Design, Setting, and PatientsRetrospective case series involving 144 adult patients admitted ...
674 CitationsSource
Cited By3
#1Zaniar Ghazizadeh (Yale University)H-Index: 1
#2Homa Majd (UCSF: University of California, San Francisco)H-Index: 1
Last. Hongyu Zhao (Yale University)H-Index: 73
view all 13 authors...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has led to a global health crisis, and yet our understanding of the disease pathophysiology and potential treatment options remains limited. SARS-CoV-2 infection occurs through binding and internalization of the viral spike protein to angiotensin converting enzyme 2 (ACE2) on the host cell membrane. Lethal complications are caused by damage and failure of vital organs that express high levels of ACE2, including the lungs, the...
1 CitationsSource
#1Liqun He (KI: Karolinska Institutet)H-Index: 18
#2Maarja Andaloussi Mäe (Uppsala University)H-Index: 7
Last. Guillem Genové (KI: Karolinska Institutet)H-Index: 18
view all 31 authors...
Accumulating clinical observations suggest pathogenesis beyond viral pneumonia and its secondary consequences in COVID-19 patients. In particular, many patients develop profound hyperinflammation and hypercoagulopathy with disseminated thrombogenesis and thromboembolism, which we observe also in a Swedish COVID-19 intensive care patient cohort. To understand these vascular manifestations, it is important to establish the potential vascular entry point(s) of the SARS-CoV-2 virus, i.e. which vascu...
1 CitationsSource
#1Christoph Muus (Broad Institute)H-Index: 2
#2Malte D LueckenH-Index: 1
Last. Christopher Smillie (Broad Institute)H-Index: 15
view all 104 authors...
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, creates an urgent need for identifying molecular mechanisms that mediate viral entry, propagation, and tissue pathology. Cell membrane bound angiotensin-converting enzyme 2 (ACE2) and associated proteases, transmembrane protease serine 2 (TMPRSS2) and Cathepsin L (CTSL), were previously identified as mediators of SARS-CoV2 cellular entry. Here, we assess the cell type-specific RNA expression of ACE2, TMPRSS2, and CTSL through an ...
18 CitationsSource